Meeting
2013 ASCO Annual Meeting
Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.
Authors
Jean-François Flejou
Department of Pathology, Hospital Saint-Antoine, AP-HP, Paris, France
Jean-François Flejou , Thierry André , Benoist Chibaudel , Aurelie Scriva , Tamas Hickish , Josep Tabernero , Jean-Luc Van Laethem , Maria Banzi , Eduard Maartense , Adi Shani , Göran Carlsson , Werner Scheithauer , Demetris Papamichael , Markus Moehler , Stefania Landolfi , Pieter Demetter , Alex Duval , Mark Lee , Soudhir Colote , Aimery De Gramont
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT00275210
Citation
J Clin Oncol 31, 2013 (suppl; abstr 3524)
DOI
10.1200/jco.2013.31.15_suppl.3524
Abstract #
3524
Poster Bd #
16
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Is the predictive and prognostic impact of sporadic and familial microsatellite instable stage III colon cancer different? A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials.
First Author: Aziz Zaanan
Poster
2018 Gastrointestinal Cancers Symposium
Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant colon cancer: Experience in Ramon y Cajal University Hospital.
First Author: Olga Martinez Saez
Poster
2018 Gastrointestinal Cancers Symposium
Results from an institutional universal reflex testing program for MSI/MMR in colorectal cancer.
First Author: Aaron J Franke
Poster
2013 Gastrointestinal Cancers Symposium
Characterization of rectal cancer in patients with lynch syndrome.
First Author: Zsofia Stadler